GCM Grosvenor Inc. GCMG Change in fair value of warrant liabilities (net of NCI)

Change in fair value of warrant liabilities (net of NCI) at other companies

Plug PowerPLUG

-$54.64M-271%

NewAmsterdam Pharma CompanyNAMS

-$5.94M+56.8%

Taysha Gene Therapies, Inc.TSHA

$0+100%

Ondas, Inc. ONDS

$4.32M—

Butterfly NetworkBFLY

-$568K-222%

Evolv Technologies Holdings, Inc.EVLV

-$2.04M-18.8%

Other financials

Income statement

See full

Revenue$124.8M-0.8%

Operating income$20.5M+33.6%

Net income$5.5M+1,081%

EPS (diluted)$0.06+400%

Balance sheet

See full

Cash & equivalents$164.4M+74.0%

Total debt$418.8M-14.2%

Total equity$25.5M+190%

Total assets$688.8M+18.8%

Cash flow

See full

Operating cash flow$51.7M+55.5%

CapEx$3.8M+229%

Free cash flow$47.9M+49.2%

Valuation

See full

Market cap$739.69M+29.3%

Enterprise value$994.15M+2.9%

P/E14.7×-18.9×

P/S1.3×+0.3×

Profitability

See full

Operating margin24.9%+5.2pp

Net margin9.1%+5.8pp

FCF margin34.3%+7.1pp

Returns & leverage

See full

Return on equity-3,556.3%—

Debt / equity16.4×—

Where this comes from

Reported directly by GCM Grosvenor Inc. in its filing.

Tagged under the XBRL concept gcm:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiabilitiesPercent.

The official record: GCM Grosvenor Inc.’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about GCM Grosvenor Inc.'s change in fair value of warrant liabilities (net of nci).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is GCM Grosvenor Inc.'s change in fair value of warrant liabilities (net of NCI)?: GCM Grosvenor Inc. (GCMG) reported change in fair value of warrant liabilities (net of NCI) of -1% in Q4 2025.
What does change in fair value of warrant liabilities (net of NCI) mean?: Measures the impact of fair value fluctuations in warrant liabilities on the company's financial results, adjusted for noncontrolling interest stakes. This metric is used to isolate the impact of derivative liability revaluations on the parent company's bottom line.